Reserpine as an uncoupler of oxidative phosphorylation and the relevance to its psychoactive properties

doi:10.1016/0006-2952(83)90449-5

Biochemical Pharmacology

Volume 32, Issue 8, 15 April 1983, Pages 1371-1377

https://doi.org/10.1016/0006-2952(83)90449-5 Get rights and content

Abstract

Many drugs differing widely in chemical structure uncouple mitochondrial oxidative phosphorylation in vitro. This observation has led to the hypothesis that in vivo uncoupling is the basis of their pharmacological activity. Serpasil, a parenteral preparation of reserpine, recently has been shown to uncouple oxidative phosphorylation in vervet monkey kidney mitochondria. Although the drug exhibits some properties of a “classical” uncoupler, our studies show that it has a dual effect on energy conservation. Reserpine released respiratory control in rat liver mitochondria only when dissolved in organic solvents (as in Serpasil) or when deprotonated. Reserpine also released the oligomycin-induced respiratory control in beef heart submitochondrial particles, and inhibited energized uptake of Ca²⁻ by rat liver mitochondria. Reserpine had a dual effect on mitochondrial ATPase: It (a) enhanced ATP hydrolysis by intact liver mitochondria, and (b) inhibited ATP hydrolysis by submitochondrial particles of beef heart. On a molar basis, reserpine was less effective than carbonyl cyanide 3-chlorophenylhydrazone in all bioenergetic reactions examined. Homogenates and mitochondria isolated from brain and liver of rats stuporous from intraperitoneally injections of Serpasil exhibited no detectable abnormalities in respiratory states and responded to known uncouplers in the expected manner. There was no evidence of in vivo uncoupling of oxidative phosphorylation as a basis of the pharmacological activity of reserpine, although interference with energy transfer may be involved in toxic manifestations of the drug. The results indicate the need for caution in interpreting the action of drugs formulated in complex pharmaceutical preparations and based solely on in vitro experiments.

References (24)

P.G. Heytler
Pharmac. Ther.
(1980)
E. Noack
Trends pharmac. Sci.
(1981)
E. Bachmann et al.
Biochem. Pharmac.
(1979)
G. Maina
Biochim. biophys. Acta
(1974)
E.C. Weinbach
Analyt. Biochem.
(1961)
E.C. Weinbach et al.
J. biol. Chem.
(1959)
C.P. Lee et al.
E.C. Weinbach et al.
J. biol. Chem.
(1966)
E.C. Weinbach
J. biol. Chem.
(1956)
M.E. Pullman et al.
J. biol. Chem.
(1960)

B.C. Pressman et al.

Biochim. biophys. Acta

(1956)

H.J. Cohen et al.

J. biol. Chem.

(1972)

Cited by (15)

Legal highs: A problem of definitions? (I)
2014, The Lancet
Mitochondria and the economy of stress (mal)adaptation
2013, Neuroscience and Biobehavioral Reviews
Citation Excerpt :
More specifically, antidepressants (sertraline, desipramine, amitriptyline, imipramine, citalopram, mirtazapine and fluoxetine) as well as mood stabilizers (valproate and olanzapine) may act generally as inhibitors of mitochondrial electron transport chain (e.g. Burkhardt et al., 1993; Daley et al., 2005; Finsterer, 2006; Hroudova and Fisar, 2011; Li et al., 2012; Maurer and Moller, 1997; Neustadt and Pieczenik, 2008). Furthermore, tricyclic antidepressants, like imipramine, fluoxetine, and chlorimipramine exhibit some characteristics of classic uncouplers of oxidative phosphorylation, as they released respiratory control, hindered ATP synthesis and enhanced ATPase activity (Hroudova and Fisar, 2011; Weinbach et al., 1983). Furthermore, in vivo studies demonstrated that nefazodone-induced hepatotoxicity attributed to inhibition of mitochondrial respiratory complexes I and IV and depolarization of the mitochondrial membrane (Dykens et al., 2008).
Stress-associated diseases, like depression have a life time prevalence of up to 20%, and approximately 18.4 million people in Europe suffer from depression. Despite decades of research, we still do not understand completely this complex brain disease. Increasing body of correlative evidence implicates mitochondria in the aetiology of depression, but the fundamental question of how suboptimal mitochondrial function causes depression remains to be answered. Here we propose that the balance between cost of adaptation to our ever changing environment (stress) and available energy (mitochondrial function) is crucial for mental health. More specifically, stress activates the brain, and changes its structure and function (neuronal plasticity). This comes at a metabolic cost that is primarily met by energy produced by mitochondria. Individuals with optimal mitochondrial function could meet critical energy demands of stress-induced neuronal-plasticity, thus are at relatively low risk for depression. In contrast, in individuals with suboptimal mitochondrial function stress-associated depletion of the brain's energy resources could ultimately compromise neuronal plasticity that in-time could render an individual vulnerable for depression. Naturally, this does not imply that all mitochondrial patients suffer from depression, or that all depressed patients have underlying mitochondrial pathology. It, however, does imply that suboptimal mitochondrial function could be pathogenic in a subgroup of patients with depression. If so, this will not only have a profound effect on our understanding of depression, but on therapy and counselling, that will also be discussed.
Role of Pterocarpus santalinus against mitochondrial dysfunction and membrane lipid changes induced by ulcerogens in rat gastric mucosa
2007, Chemico-Biological Interactions
Citation Excerpt :
This usually results in diminished cellular ATP production [39]. Reserpine, has been shown to uncouple oxidative phosphorylation in mitochondria [40] and has been reported to deplete ATP and decrease ADP/O ratio [41]. Gastric mucosal injury also results in ATP depletion in gastric mucosa [42] which concurs with the present study that ibuprofen and reserpine caused mitochondrial ATP depletion leading to mitochondrial dysfunction.
Free radicals produced by ulcerogenic agents affect the TCA cycle enzymes located in the outer membrane of the mitochondria. Upon induction with ulcerogens, peroxidation of membrane lipids bring about alterations in the mitochondrial enzyme activity. This indicates an increase in the permeability levels of the mitochondrial membrane. The ability of PSE to scavenge the reactive oxygen species results in restoration of activities of TCA cycle enzymes. NSAIDs interfere with the mitochondrial β-oxidation of fatty acids in vitro and in vivo, resulting in uncoupling of mitochondrial oxidative phosphorylation process. This usually results in diminished cellular ATP production. The recovery of gastric mucosal barrier function through maintenance of energy metabolism results in maintenance of ATP levels, as observed in this study upon treatment with PSE. Membrane integrity altered by peroxidation is known to have a modified fatty acid composition, a disruption of permeability, a decrease in electrical resistance, and increase in flip-flopping between monolayers and inactivated cross-linked proteins. The severe depletion of arachidonic acid in ulcer induced groups was prevented upon treatment with PSE. The acid inhibitory property of the herbal extract enables the maintenance of GL activity upon treatment with PSE. The ability to prevent membrane peroxidation has been traced to the presence of active constituents in the PSE. In essence, PSE has been found to prevent mitochondrial dysfunction, provide mitochondrial cell integrity, through the maintenance of lipid bilayer by its ability to provide a hydrophobic character to the gastric mucosa, further indicating its ability to reverse the action of NSAIDs and mast cell degranulators in gastric mucosa.
Effect of catecholamine depletion on oxidative energy metabolism in rat liver, brain and heart mitochondria; use of reserpine
2000, Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology
Regulation of mitochondrial functions in vivo by catecholamines was examined indirectly by depleting the catecholamines stores by reserpine treatments of the experimental animals. Reserpine treatment resulted in decreased respiratory activity in liver and brain mitochondria with the two NAD⁺-linked substrates: glutamate and pyruvate+malate with succinate ATP synthesis rate decreased in liver mitochondria only. With ascorbate+TMPD system, the ADP/O ratio and ADP phosphorylation rate decreased in brain mitochondria. For the heart mitochondria, state 3 respiration rates decreased for all substrates. In the liver mitochondria basal ATPase activity decreased by 51%, but in the presence of Mg²⁺ and/or DNP increased significantly. In the brain and heart mitochondria ATPase activities were unchanged. The energy of activation in high temperature range increased liver mitochondrial ATPase while in brain mitochondria reserpine treatment resulted in abolishment in phase transition. Total phospholipid (TPL) content of the brain mitochondria increased by 22%. For the heart mitochondria TPL content decreased by 19% and CHL content decreased by 34%. Tissue specific differential effects were observed for the mitochondrial phospholipid composition. Liver mitochondrial membranes were more fluidized in the reserpine-treated group. The epinephrine and norepinephrine contents in the adrenals decreased by 68 and 77% after reserpine treatment.
Mitochondrial alterations in the brain of the rat caused by chlorphentermine
1986, Neuropharmacology
The effects of chlorphentermine on the bioenergetics and activity of monoamine oxidase in mitochondria from the brain of the rat were examined. Oxidation rates of glutamate and succinate were investigated in the presence of chlorphentermine (0.1–5.0 mM). In small concentrations (0.1–1.0 mM), chlorphentermine decreased the respiratory control ratio and the adenosine diphosphate oxygen (ADP/O) ratio, and stimulated state four respiration. State three respiration and the uncoupled state were also decreased, but to a lesser degree. In the presence of larger concentrations of chlorphentermine (1.0–5.0 mM), the respiration in states four, three, and in the uncoupled state, as well as the respiratory control ratio and $ADP O$ ratio, were decreased significantly. These data indicate that chlorphentermine functions as an uncoupler of oxidative phosphorylation. Oxidation of norepinephrine, serotonin, octopamine, tyramine and dopamine by monoamine oxidase (MAO), an enzyme marker of the outer mitochondrial membrane, was inhibited in the presence of 0.01 to 0.1 mM of chlorphentermine. Oxidation of tryptamine and benzylamine was unaffected. A kinetic study of the oxidation of serotonin in the absence and presence of chlorphentermine (0.025–0.1 mM) indicated that both the V_max and K_m were affected. This drug is an inhibitor of monoamine oxidase of mitochondria of the brain with mixed type inhibition. These combined data show that chlorphentermine affects biochemical processes in both inner and outer mitochondrial membranes.
Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria
1986, Biochemical Pharmacology
The effects of impramine and chlorimipramine on energy-linked reactions in mitochondria were characterized. Both compounds exhibited some characteristics of classical uncouplers of oxidative phosphorylation, i.e. they released respiratory control, hindered ATP synthesis, and enhanced ATPase activity of isolated rat liver mitochondria. Unlike classical uncouplers, however, these compounds only weakly stimulated proton uptake in intact mitochondria. They also exhibited unusual effects on energy-linked reactions in beef heart submitochondrial particles (SMP). Both compounds inhibited NADH oxidation in SMP in an “oligomycin-like” manner, and inhibited ATPase activity of SMP and the soluble F₁-ATPase. In contrast, the drugs weakly inhibited ATPase activities of bovine adrenal gland chromaffin granules and resealed granule ghosts. The mechanisms responsible for the multiple effects on mitochondrial energy-linked processes are unclear. They may be related to the hydrophobicity of the drugs, as has been shown for other hydrophobic amines.

View all citing articles on Scopus

View full text

Reserpine as an uncoupler of oxidative phosphorylation and the relevance to its psychoactive properties

Abstract

Pharmac. Ther.

Trends pharmac. Sci.

Biochem. Pharmac.

Biochim. biophys. Acta

Analyt. Biochem.

J. biol. Chem.

J. biol. Chem.

J. biol. Chem.

J. biol. Chem.

Biochim. biophys. Acta

J. biol. Chem.